ISRG241018P460000
- 6.52
- +2.88+79.12%
Intuitive Surgical Newsroom
Baird Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Raises Target Price to $565
A Quick Look at Today's Ratings for Intuitive Surgical(ISRG.US), With a Forecast Between $500 to $570
Maintaining a Buy Rating: Intuitive Surgical's Unchallenged Market Dominance Despite New Competition
Intuitive Surgical Analyst Ratings
Mizuho Adjusts Price Target on Intuitive Surgical to $500 From $440
Intuitive Surgical Is Maintained at Buy by Truist Securities
BTIG Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Raises Target Price to $518
Intuitive Surgical Analyst Ratings
Intuitive Surgical (ISRG) Receives a Hold From Deutsche Bank
J.P. Morgan Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Raises Target Price to $575
RBC Capital Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Raises Target Price to $525
BTIG Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Maintains Target Price $494
Buy Rating on Intuitive Surgical: Expanding Robotic Surgery Into Emergency Procedures Promises Market Growth
Intuitive Surgical Is Maintained at In-Line by Evercore ISI Group
Intuitive Surgical Analyst Ratings
Evercore ISI Adjusts Intuitive Surgical Price Target to $475 From $410
BofA Securities Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Maintains Target Price $550
BofA Securities Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Raises Target Price to $550
Analysts Have Conflicting Sentiments on These Healthcare Companies: Intuitive Surgical (ISRG), HCA Healthcare (HCA) and Teleflex (TFX)
BTIG Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Maintains Target Price $494